Veselka V.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Pharmacokinetic Evaluation of LY03010 and Its Relative Bioavailability Compared to Paliperidone Palmitate in Schizophrenia Patients
- A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NBI-1117570 in Hospitalized Adults with Schizophrenia
- Evaluation of Long-Term Safety and Tolerability of Cariprazine in Adolescent Patients with Schizophrenia: A 2-Year, Multicenter, Open-Label Study
Data & Insights
Has run more than one trial at 36 of 74 partner sites.
Specializations
Schizophrenia
Veselka Vasileva is involved in clinical research focused on schizophrenia, with attention to symptom control, behavioral and psychological symptoms, and treatment options for both adult and adolescent populations. The portfolio also includes work in inpatient psychiatry and the management of inadequately controlled disease.
- Adjunctive treatment for persistent schizophrenia symptoms
- Adolescent schizophrenia in patients aged 13 to 17 years
- Inpatient adult schizophrenia and acute psychiatric care
- Behavioral and psychological symptom management
Her research activity is centered at Medical Center VAS OOD and Multiprofile Hospital For Active Treatment - Targovishte AD in Targovishte, Bulgaria.
Major Depressive Disorder
Another major area of interest is major depressive disorder, including studies of adjunctive antidepressant therapy and long-term treatment evaluation in adults. The clinical focus extends to persistent depressive symptoms and therapeutic strategies for patients with incomplete response to standard care.
- Adjunctive treatment in major depressive disorder
- Depressive symptom reduction in adult participants
- Long-term safety and tolerability in depression care
This area reflects a sustained interest in expanding therapeutic options for treatment-resistant depression and related mood disorders.
Generalized Anxiety Disorder
Her clinical research landscape includes generalized anxiety disorder, with emphasis on patients who have had an inadequate response to ongoing treatment. The therapeutic interest is directed toward both adjunctive and monotherapy approaches in anxiety management.
- Generalized anxiety disorder with inadequate treatment response
- Adjunctive anxiety treatment
- Monotherapy approaches in anxiety care
These studies place anxiety disorders within a broader psychiatric treatment portfolio that includes resistant and partially controlled conditions.
Cognitive Disorder
Veselka Vasileva is also linked to research on cognitive disorder within the context of schizophrenia, highlighting interest in cognitive impairment and its impact on psychiatric functioning. This area connects symptom management with restoration of cognitive performance.
- Cognitive impairment associated with schizophrenia
- Cognitive performance in psychiatric illness
- Neuropsychiatric symptom burden
The focus on cognition adds a distinct therapeutic dimension to her psychiatric research profile.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.